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Background: People who experience homelessness and those vulnerably 17 
housed experience disproportionately high rates of drug use and associated harms, 18 
yet barriers to services and support are common. We undertook a systematic ‘review 19 
of reviews’ to investigate the effects of interventions for this population on substance 20 
use, housing, and related outcomes, as well as on treatment engagement, retention 21 
and successful completion. 22 
Methods and findings: We searched ten electronic databases from 23 
inception to October 2020 for reviews and syntheses, conducted a grey literature 24 
search, and hand searched reference lists of included studies. We selected reviews 25 
that synthesised evidence on any type of treatment or intervention that reported 26 
substance use outcomes for people who reported being homeless. We appraised the 27 
quality of included reviews using the Joanna Briggs Institute Critical Appraisal 28 
Checklist for Systematic Reviews and Research Syntheses and the Scale for the 29 
Assessment of Narrative Review Articles. Our search identified 843 citations, and 25 30 
reviews met the inclusion criteria. Regarding substance use outcomes, there was 31 
evidence that harm reduction approaches lead to decreases in drug-related risk 32 
behaviour and fatal overdoses, and reduce mortality, morbidity, and substance use. 33 
Case management interventions were significantly better than treatment as usual in 34 
reducing substance use among people who are homeless. The evidence indicates 35 
that Housing First does not lead to significant changes in substance use. Evidence 36 




Conclusions: People who are homeless and use drugs experience many 38 
barriers to accessing healthcare and treatment. Evidence regarding interventions 39 
designed specifically for this population is limited, but harm reduction and case 40 
management approaches can lead to improvements in substance use outcomes, 41 
whilst some housing interventions improve housing outcomes and may provide more 42 
stability. More research is needed regarding optimal treatment length as well as 43 
qualitative insights from people experiencing or at risk of homelessness. 44 
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Introduction  61 
Homelessness encompasses a range of housing situations including both sheltered 62 
(e.g. temporary accommodation) and unsheltered settings (e.g. the streets), but 63 
lacks a standardised definition [1,2]. FEANTSA have previously developed a 64 
typology seeking to define homelessness in an operational way [3]. Through this, 65 
homelessness can be defined based on four categories: rooflessness; 66 
houselessness; insecure housing; and inadequate housing [3]. The Canadian 67 
Observatory on Homelessness (COH) have also developed a typology in an attempt 68 
to improve understanding of the term [4]. Similar to FEANTSA, COH define 69 
homelessness as encompassing a range of living situations including: people living 70 
unsheltered; people who are in emergency shelters; people who are in temporary 71 
accommodation; and those at risk of homelessness and whose housing situations 72 
are precarious [4]. In the UK and Irish policy context, the definition of homelessness 73 
is also typically expanded to include people ‘at risk’ of homelessness. Recent 74 
estimates suggest that 307,000 people in the UK [5], 567,715 in the USA [6], and 75 
235,000 in Canada [7], experience homelessness in a year, with the numbers 76 
increasing [8]. Due to variation in the definition of homelessness the true magnitude 77 
of the problem may be higher still. The route into homelessness is complex and is 78 
generally a result of many contributing factors. Systemic or societal barriers are key 79 
drivers, for example lack of affordable housing, access to resources, or 80 
discrimination [4]. Poverty is also an important factor [9], with COH reporting that 81 
homelessness is directly linked to the inequalities in financial support for people who 82 
are often in crisis situations [4]. Other individual cirumstances can increase a 83 
person’s risk of homelessness, including childhood trauma, mental health problems, 84 





People who are homeless, and those who are vulnerably housed (defined as 87 
experiencing prior homelessness or having frequent housing transitions [11]), 88 
experience disproportionately high rates of substance use [12–14], as well as poorer 89 
physical [12,14] and mental health [15–17] than the general population. People who 90 
are homeless also have a higher risk of developing health problems that are 91 
relatively rare within the general population, such as those caused by blood-borne 92 
viruses (BBVs) including hepatitis and human immunodeficiency virus (HIV) [17,18]. 93 
Moreover, the longer a person is homeless, the higher their risk of ill health and 94 
premature death [19], with mortality rates estimated to be between three to four 95 
times higher than in the general population [14,20]. 96 
 97 
Despite higher rates of physical and mental ill health, people who are homeless 98 
attend primary care and preventive services, such as screenings and check-ups, 99 
less often than the general population [21]. Barriers to accessing appropriate care 100 
can include: negative previous experiences of such care; other priorities such as 101 
shelter and food; and access barriers such as perceived prejudice and judgemental 102 
staff, poor coordination between healthcare services, cost of medication, lack of 103 
continuity of care, challenges with strict appointment times, and complex 104 
administrative processes [21,22]. These barriers can lead to delayed or no treatment 105 
which, in turn, can increase the risks of more serious health problems [23]. Indeed, 106 
globally, the rate of hospital admissions for people who are homeless has been 107 





Individuals experiencing homelessness are also less likely to access, and more likely 110 
to disengage from, substance use treatment [25]. Individuals may use substances as 111 
a way to cope with the trauma of homelessness, stress, and adversity [26–28]. 112 
Previous trauma experienced both in childhood and adulthood, as well as vicarious 113 
trauma and posttraumatic stress disorder, can also influence substance use [29]. 114 
Despite the considerable unmet care needs of this population, people who 115 
experience both homelessness and problem substance use (defined as ‘the use of 116 
drugs and/or alcohol in a way that had a negative effect on their lives’) often face 117 
overlapping barriers to accessing care. These include stigma related to care itself 118 
[30], as well as sub-optimal treatment lengths and judgemental staff [31]. Moreover 119 
abstinence-based Treatment First [TF] housing services can be inaccessible to many 120 
of those in need of housing, creating more difficulties [32,33]. Together, these 121 
barriers can contribute to mistrust of health services, maintenance of low levels of 122 
access and adherence to care, and an increase in people’s perceived loss of control 123 
and lack of mastery over their lives [34–36]. 124 
 125 
Existing treatment options for problem substance are diverse, and can be placed on 126 
a continuum ranging from harm reduction to abstinence-based approaches. Harm 127 
reduction approaches include pragmatic interventions, policies, and programmes, 128 
but do not require a person to stop using drugs as a condition of support [37]. 129 
Research evidence and policy guidance supports provision of harm reduction and 130 
abstinence orientated actions depending upon target population need [22,31,38]. 131 
Evidence regarding how treatment for problem substance use is best delivered to 132 
those experiencing homelessness is limited, although engaging, flexible services 133 




accessed treatment, challenges associated with continued engagement with 135 
treatment and recovery as a result of being homeless often remain [31].   136 
 137 
Several systematic reviews and primary research studies have examined the 138 
effectiveness of various specific interventions (such as case management or 139 
Housing First (HF) approaches) for people who are homeless, and for people with 140 
problem substance use. However, evidence that pools and synthesises the available 141 
data is lacking. Moreover, evidence pertaining specifically to people who experience 142 
both homelessness and problem substance use is limited. This ‘systematic review of 143 
reviews’ aimed to address this gap by synthesising all available evidence on the 144 
effectiveness of treatments and interventions for this specific population. The review 145 
includes housing interventions, peer support interventions, and harm reduction 146 
approaches, among others. This review evaluates the effects of these interventions 147 
on those who use services (referred to as ‘clients’ throughout the review), regarding 148 
substance use, housing, and ‘other’ outcomes, as well as on treatment entry, 149 
engagement, retention and successful completion. We also identified components of 150 




Study design 155 
 156 
This systematic review of reviews provides a synthesis of international evidence 157 
regarding interventions in primary care, mental health, and drug treatment settings, 158 
for people who are homeless who use drugs. Given the large body of existing 159 
evidence available on the topic, a systematic review of reviews was considered to be 160 




with guidelines from the Joanna Briggs Institute [41], and was reported according to 162 
the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) 163 
guidelines [42] (S1 PRISMA checklist). No protocol was registered with an open-164 
access registry (e.g. PROSPERO) prior to publication. 165 
 166 
This review was undertaken as part of a larger piece of research commissioned by 167 
the Health Research Board, Ireland, and undertaken by the same authors in 2019-168 
2020 [43]. The larger study combined an analysis of current drug trends and 169 
provision of services in Ireland (with contextual mapping) with the systematic review. 170 
This current review provides an updated search and new data. The main outcomes 171 
of this review focused on: i) substance use; ii) housing; and iii) ‘other’ outcomes. We 172 
also extracted and synthesised, where possible, information regarding treatment 173 
entry/engagement and retention (engaging the population of interest to enter 174 
treatment/engage with a service), and successful completion of treatment (attrition 175 
rates throughout treatment duration).  176 
 177 
Search strategy and selection criteria 178 
 179 
The PICOS framework (population, interventions, comparators, outcomes, and study 180 
design) [44] was used to formulate the inclusion/exclusion criteria (see Table 1) and 181 
identify appropriate literature search terms. 182 
 183 
Table 1. Inclusion/exclusion criteria 184 
Inclusion Exclusion 
Populations 
People experiencing homelessness and drug use 
(including poly-substance use – i.e. concurrent use of 
various substances) 
 
People who are not 
deemed homeless; 





Range of drugs used both problematically and/or 
recreationally, including PIEDs 
 






Problem drug use treatment (including poly-substance use) 
Harm reduction approaches 
Interventions in primary care for drug use 












Reduced drug consumption 
Reduced overdoses (fatal and non-fatal) 
Reduced drug related harm 
Improved quality of life 
Improved health outcomes 




Alcohol only related 
outcomes 
Study design 
Review (including systematic review, meta-analysis, 
evidence synthesis, realist review, mixed methods review, 
qualitative synthesis, meta-epidemiology, integrative 





An information specialist (MM) led the development and application of the search 186 
strategies, supported by all members of the research team. The searches were 187 
conducted across 10 electronic databases (see Table 2). All searches were run on 188 
30 December 2019, with an updated search conducted on 3 October 2020. We also 189 
searched a range of organisational websites from December 2019 to January 2020 190 
to ensure that any relevant reviews situated in the grey literature were identified (S2 191 
Table). Full search strategies can be found in S3 Search strategy. Reference details 192 
identified through the literature search were collated and managed using EndNote. 193 
Reference lists of included articles were screened for additional reviews. No date or 194 
language restrictions were included in order to minimise bias and ensure that all 195 
relevant reviews could be captured. Two reviews written in languages other than 196 




Translate and deemed of acceptable quality by the research team for the purposes 198 
of data extraction. 199 
 200 








Cochrane Database of Systematic Reviews 
Joanna Briggs Institute Database of Systematic Reviews 
Heath Technology Assessments (via National Institute for Health 
Research Journals) 
The Campbell Collaboration  
 202 
 203 
One reviewer (JM) screened all titles and abstracts, alongside the full-text of articles 204 
that were considered relevant. A second reviewer (WM) independently assessed 205 
20% of all titles and abstracts to ensure inter-rater reliability, as deemed to be good 206 
practice in rapid systematic review methodology [45]. The relevance of each article 207 
was assessed according to the criteria set out in Table 1. Any discrepancies were 208 
resolved by consensus or, if necessary, by consulting a third reviewer (HC). As a 209 
second reliability check TP, HC, WM, and JM discussed all identified relevant papers 210 
in consultation with HS. By consensus, it was agreed that only reviews where at 211 
least 40% of all included papers were relevant to substance use and homelessness 212 
were to be included, to ensure that the review maintained a firm focus on both topics. 213 
Adopting a minimum percentage in this context has also been used in other 214 
systematic reviews [46]. Reviews of both quantitative and qualitative studies were 215 
included, as were non-systematic reviews. Papers reporting pooled data or meta-216 





Quality assessment 219 
 220 
Reviews were not excluded based on quality appraisal scores but evidence quality 221 
was noted in accordance with the recommendations proposed by the Centre for 222 
Reviews and Dissemination [47]. Two reviewers (JM and HC) independently 223 
assessed the quality of the included systematic reviews using the JBI Critical 224 
Appraisal Checklist for Systematic Reviews and Research Syntheses [41] (S4 JBI 225 
checklist); and the quality of the non-systematic reviews using the Scale for the 226 
Assessment of Narrative Review Articles (SANRA) [48] (S5 SANRA critical appraisal 227 
tool). Any disagreement in scores was resolved through consensus and, if 228 
necessary, by a third reviewer (WM). Overall, the quality of the included systematic 229 
reviews was moderate, with three achieving the highest possible score of 11, and six 230 
receiving a score of six or lower. The included non-systematic reviews were 231 
apparised to be of moderate to high quality. Quality appraisal allowed for the study 232 
strengths and weaknesses to be considered but papers were not excluded based on 233 
their scores. The final scores are presented in S6 Table. 234 
 235 
Data analysis  236 
 237 
Data relating to study design and key characteristics, including populations, 238 
interventions, outcomes, and implications for policy and practice, were extracted by 239 
one reviewer (JM) into an Excel spreadsheet. Data from the reports identified 240 
through the grey literature search were extracted into the same spreadsheet by a 241 
second reviewer (WM). The data extraction table (S7 Table) was shared with other 242 





As this systematic review of reviews includes both quantitative and qualitative 245 
reviews regarding diverse types of interventions and outcomes, pooling of data was 246 
not possible, and a narrative synthesis was deemed the most suitable option for data 247 
analysis. One author (JM) summarised included studies in a narrative synthesis 248 
using textual description of each study included. Thematic summaries were 249 
developed based on the type of intervention in the included studies which enabled 250 
the synthesis and supported comparisons to be made between each study [49]. 251 
Although the search focused on controlled drugs, the team also extracted data on 252 
about alcohol, prescription drug and tobacco use, if these were included. One of the 253 
reviews previously identified for inclusion [50] only presented an abstract from a 254 
conference, with the full review not available/not published. Full data extraction was 255 




The literature searching and screening process are shown using a PRISMA flow 260 
diagram [51] (Fig 1). In total, including initial and updated searches together, 843 261 
reviews were identified via database searches, with a further four identified in grey 262 
literature searches. Six hundred and thirty two reviews were screened against the 263 
inclusion criteria and 39 were assessed at full text, of which 18 were excluded (Fig 264 
1). Across both searches, a total of 25 reviews were included, 24 of which were fully 265 
synthesised (full text was not available for one of the included reviews thus making 266 
its inclusion in final synthesis not possible). Twenty one reviews were published in 267 
the scientific literature, and four were grey literature reviews.   268 
 269 





[FIG 1. HERE] 272 
 273 
Characteristics of the included reviews 274 
  275 
Included reviews were published between 2004 and 2020, and consisted of: four 276 
grey literature reports [39,52–54]; 18 systematic reviews [2,31,61–68,46,50,55–60], 277 
two of which also included a meta-analysis [2,65]; and three non-systematic reviews 278 
[69–71]. Thirteen reviews included quantitative studies only, 11 included any study 279 
type/mixed designs, including one realist synthesis [62], two systematic review of 280 
reviews [52,60], one ‘state of the art’ review [61], and one review was a meta-281 
ethnography of qualitative studies [31]. The number of included studies per review 282 
ranged from four [2] to 151 [53], with five reviews not reporting how many studies 283 
were included in the final synthesis [39,54,68,70,71]. 284 
 285 
Eleven of the reviews were undertaken in the United Kingdom (UK), four in the 286 
United States of America (USA), six in Canada, three in Europe (Spain, Ireland, and 287 
a Dutch/Belgian collaboration), and one was an international collaboration 288 
(Switzerland, the UK, and Canada). Nearly all reviews (22/25) were international in 289 
focus, with two focusing on the USA and one on the UK only. The majority of primary 290 
studies were undertaken in the USA.  291 
 292 
Overview of the included reviews – primary focus  293 
The included reviews were diverse in terms of their primary focus and included a 294 
range of interventions (Table 3). Two of the included reviews focused on any/all 295 




variety of programmes ranging from harm reduction for people who use drugs to 297 
sexual health promotion programmes. 298 
 299 
Table 3. Primary focus of included reviews 300 






(including Housing First (HF) 
initiatives) 
HF focuses on providing 
immediate, permanent, low-
barrier, non-abstinence-based 
supportive housing for 
individuals with lived experience 
of homelessness. 













Co-occurring serious mental 
health problems and 
alcohol/drug use (COSMHAD)  
Residential programmes and 
community-based treatment. 
Residential programmes can 
integrate mental health 
treatment, substance use 
interventions, housing, and other 
types of support. Community-
based treatment can also 
include integrated treatment. 
4 Brunette et al. 
(2004) [69]; 
Minyard et al. 
(2019) [53]; 
O’Campo et al. 
(2009) [62]; Sun 
(2012) [71] 
Case management Case management is a strategy 
to support rapid rehousing, 
especially for those with 
complex needs. It provides 
outreach, assessment, planning, 
linkage, monitoring, and 
advocacy services. This strategy 
typically provides support in 
developing independent living 
skills, acute care in crisis 
situations, and support with 
medical and psychiatric 
treatment (de Vet et al., 2013). 
4 de Vet et al. 
(2013) [58]; 




et al. (2019) 
[67]; Ponka et 
al., (2020) [63] 
Treatment for problem 
substance use 
Treatment approaches for 
problem substance use are wide 
ranging and can be placed on a 
continuum, ranging from harm 
reduction to abstinence-based 
approaches. 
3 Bates et al. 
(2017) [52]; 




Any type of healthcare/ 
treatment/intervention 
These included: adequate oral 
opioid maintenance therapy; 





tetanus and Hepatitis A, B, and 
C immunisations; safer injecting 
advice and access to NSPs; 
supervised consumption 
facilities (SCF); peer distribution 
of take-home naloxone (THN); 
assertive outreach programmes; 
supportive programmes for 
substance dependence; and 





Peer support  Peers with experience of 
homelessness offer support to 
those currently experiencing 
homelessness. Intentional peer 
support (IPS) is fostered and 
developed by professional 
organisations, formalising this 
process. 
2 Barker and 
Maguire (2017) 
[46]; Miler et al. 
(2020) [61] 
Harm reduction (Reviews that 
were specifically about harm 
reduction interventions for 
people who are homeless who 
use drugs) 
Two important harm reduction 
interventions for injecting drug 
users are opioid substitution 
therapy (OST) (to reduce drug 
dependence and injecting 
frequency) and the provision of 
clean injecting equipment 
through needle and syringe 
programmes (NSPs); to reduce 
unsafe injecting, i.e. sharing 
used syringes). Other harm 
reduction interventions include 
THN and SCFs. 
2 Turner et al. 
(2011) [65]; 
Magwood et al. 
(2020) [60] 
Emergency department (ED) 
interventions 
These are interventions 
provided/initiated at the ED, 
aiming to improve health and/or 
access to the social 
determinants of health. These 
include case management, HF, 
substance use interventions, 
and ED-based resource desks 
and ED compassionate care. 
1 Formosa et al. 
(2019) [50] 
Sexual health promotion This included programmes 
combining HIV education; 
alcohol and drug counselling; 
benefits and housing assistance; 
acquired immunodeficiency 
syndrome (AIDS) videotapes 
and group sessions on AIDS 
education; HIV testing; condom 
use; use of bleach to sterilise 
injecting equipment; signposting 
to community resources; and 
tailored individual sessions. 







The included reviews varied in terms of their inclusion of populations of interest, with 302 
only a few focusing specifically on people who use drugs who reported being 303 
homeless [31,61,64,70]. Others focused on people who were homeless and had co-304 
occurring serious mental health problems and alcohol/drug use (COSMHAD) [62,69] 305 
people who were homeless [59], or people who were homeless with mental health 306 
problems [56] as the primary population of interest, where substance use was 307 
secondary. Full details of the studies are presented in S7 Table.  308 
 309 
There were notable differences in the proportion of participants who were homeless 310 
between the primary studies in the included reviews. For this reason some adopted 311 
minimum percentages for inclusion, for example Barker and Maguire [46] only 312 
included reviews when a minimum of 30% of included studies had a focus on 313 
homelessness, and Ponka et al. [63] required more than 50% of any study 314 
participants to be identified as ‘homeless’. The definition of homelessness also 315 
varied between the reviews, and between the included primary studies, which made 316 
it difficult to make direct comparisions between reviews.  317 
 318 
Treatment outcomes  319 
 320 
The included reviews discussed a wide range of outcomes, including: those relating 321 
to substance use (reduction in drug and alcohol use (or tobacco); relapse rates; fatal 322 
and non-fatal opioid overdose rates; mean injecting frequency; and increase in 323 
treatment entry); housing; and ‘other’ outcomes, for example: well-being/quality of 324 
life (QoL); mental health; criminal justice system involvement; and societal 325 
integration. Four reviews [31,62,69,71] grouped into ‘components of good practice’ 326 




investigating types of specific treatments. These outcomes have been synthesised 328 
below. 329 
 330 
Treatment outcomes: substance use 331 
 332 
A variety of intervention types are available for people experiencing homelessness 333 
with concurrent problem substance use. These outcomes were reported in all 25 334 
reviews, with mixed results overall. Regarding harm reduction interventions, these 335 
can lead to decreases in drug-related risk behaviour (e.g. needle sharing) for people 336 
who are homeless and use drugs [65], and co-delivery of a number of such 337 
approaches together (‘full harm reduction’) can lead to better outcomes than single 338 
harm reduction interventions. For example, full harm reduction, defined as receiving 339 
both opioid substitution therapy (OST) and high needle and syringe programme 340 
(NSP) coverage (100% versus <100% needles per injection), was associated with a 341 
48% reduction in self-reported needle sharing, and in mean injecting frequency by 342 
20.8 injections per month [65]. Wright and Tompkins [68] suggested that there was 343 
emerging evidence for the effectiveness of supervised consumption facilities (SCFs), 344 
as well as for peer distribution of take-home naloxone (THN), in reducing drug-345 
related deaths for people who are homeless who inject drugs. Similarly, a recent 346 
study by Magwood et al. [60] concluded that SCFs decreased fatal overdose rates 347 
and reduced other high risk behaviours; and pharmaceutical interventions (such as 348 
OST) also reduced mortality, morbidity, and substance use [60]. Bates et al. [52] also 349 
concluded that OST led to reductions in drug use but, in contrast to Turner et al. [65], 350 
they did not find evidence of harm reduction interventions leading to a reduction in 351 





For people with COSMHAD, Minyard et al. [53] presented some evidence for the 354 
effectiveness of an integrated day programme in reducing substance use rates, and 355 
Wright and Tompkins [68] reported that residential interventions led to greater 356 
reductions in drug use than community interventions. When comparing housing and 357 
support services with less intensive types of interventions, substance use outcomes 358 
were not significantly different [59]. However, there was some support for 359 
psychosocial rehabilitation, and an abstinence-contingent multifactorial housing 360 
programme with behavioural and work therapy interventions, in reducing substance 361 
use [59]. Moreover, there was support for education programmes in reducing 362 
injection drug use, specifically among homeless women [59]. 363 
 364 
Regarding housing interventions, the reviews suggested neither a positive nor a 365 
negative impact of HF on substance use, but it was deemed potentially helpful for 366 
stabilisation. For example, Pleace and Quilgars [54] reported no significant 367 
difference between HF participants and a control group in terms of either alcohol or 368 
drug use at 24- or 48-months post intervention in one of their included studies, with 369 
small but statistically significant improvements in alcohol and drug use over 24- 370 
months in another. Both Baxter et al. [2] and Beaudoin [55] found that HF produced 371 
no clear differences in substance use when compared with treatment as usual (TAU) 372 
which consisted of diverse alternative homeless services and interventions. 373 
Beaudoin [55] found no differences between those involved in HF interventions and 374 
those accessing traditional psychosocial interventions. However, Baxter et al. [2] 375 
reported that, in one of their included studies, participants housed together in 376 




greater improvements in problem substance use than those in scattered-site 378 
housing.  379 
 380 
The evidence concerning permanent supportive and recovery housing (supportive 381 
housing promoting abstinence, specifically for those with alcohol or other substance 382 
use problems) [56,57] respectively, also yielded mixed findings regarding substance 383 
use. Chambers et al. [57] found some evidence of the effectiveness of recovery 384 
housing and, although all evidence in their review stemmed from the USA, the 385 
authors suggested that the model could be replicated elsewhere (specifically the UK 386 
where the authors were based) and offered as an alternative to HF, allowing people 387 
to live in an abstinent community. Chambers et al. [57] concluded that recovery 388 
houses can improve personal well-being for some clients through promoting 389 
abstinence from alcohol or drugs.  390 
 391 
Regarding case management interventions, Torres Del Estal and Álvarez [64] 392 
concluded that this type of intervention can lead to a reduction in substance use, 393 
either as a single intervention or in combination with others. De Vet et al. [58] 394 
provided some evidence that standard case management (SCM) is effective for 395 
people who are homeless and use drugs in reducing problem substance use, more 396 
so than TAU. Similarly, Ponka et al. [63] reported that SCM had both limited and 397 
short term effects on problem substance use, such as decreased problem substance 398 
use. Regarding assertive community treatment (ACT), findings were largely non-399 
significant or inconsistent [58,67]. Critical time intervention (CTI) was found to be 400 




homeless with mental health problems, and intensive case management (ICM) led to 402 
substantial reductions in both drug and alcohol use [63]. 403 
 404 
Peer support interventions found some positive effects of intentional peer support 405 
(IPS), which is the type of peer support that is fostered and developed by 406 
professional organisations, on substance use, with an overall reduction in harm 407 
related to substance use, relapse rates, amount of money spent on substances, and 408 
number of days using drugs or alcohol [46]. Miler et al. [61] also reported a number 409 
of positive substance use outcomes relating to peer support, from both qualitative 410 
and quantitative studies. These included, for example, a significant reduction in 411 
mean daily cigarette use combined with a considerable reduction in self-reported 412 
illicit drug use, in a peer support smoking cessation study for people who were 413 
homeless with poly-substance use [61]. 414 
 415 
Lastly, Wright and Walker [66] examined the effectiveness of sexual health 416 
promotion interventions for people experiencing homelessness and using drugs, 417 
concluding overall that such interventions resulted in increased knowledge of drug-418 
related harms and initially led to a reduction in drug use. Results regarding longer 419 
term effects (e.g. over a 24-month period) were mixed. 420 
 421 
Overall, the evidence suggests that the more integration there is between 422 
programmes and services (as opposed to parallel service provision) when supporting 423 
people who have multiple needs, the better the outcomes. There is some evidence 424 
to suggest that harm reduction approaches can lead to decreases in drug-related 425 




cause mortality, morbidity, and substance use. Case management interventions, 427 
especially CTI and ICM, have been found to be significantly better than TAU in 428 
reducing substance use among people who were homeless, including those with 429 
mental health problems. Peer support interventions can have a positive impact on 430 
substance use outcomes. Lastly, the evidence regarding substance use outcomes 431 
and HF seems to indicate that HF does not lead to significant changes in substance 432 
use. 433 
 434 
Treatment outcomes: housing 435 
 436 
Housing outcomes were reported in 10 of the included reviews [2,46,50,55–437 
58,61,63,70].  438 
 439 
Regarding HF, large improvements in housing stability were reported in one review, 440 
with intervention participants spending more days housed and more likely to be 441 
housed at 18–24 months post-intervention [2]. Similarly, Beaudoin [55] reported that 442 
HF resulted in more time spent in housing and less time on the street when 443 
compared with case management and TF programmes. Similarly, Kertesz et al. [70] 444 
concluded that, despite limited data, HF appears to improve housing retention in 445 
people experiencing homelessness and problem substance use. Moreover, 446 
Chambers et al. [57] found moderate-strength evidence for a positive effect of 447 
supportive housing on housing stability, including strong evidence that HF could 448 
improve housing stability. A range of factors which influenced the effectiveness of HF 449 
were identified, including fidelity to core components, and whether the service 450 
delivered a congregate or a scattered model. Lastly, Benston [56] found that most 451 




management, offered specifically to people who were homeless with mental health 453 
problems, remained in housing for at least 12-months, or experienced more days 454 
housed than homeless, relative to a comparison group. 455 
 456 
Relating to case management interventions, there was some evidence that SCM 457 
was effective for people who were homeless and using substances in improving 458 
housing stability [58], and for having both limited and short term effects on housing 459 
outcomes [63]. On the other hand, for the same subgroup, findings regarding the 460 
effectiveness of ICM were mixed or inconsistent [58], with some small positive 461 
effects on housing outcomes and reductions in the number of days spent homeless, 462 
but no significant effect on the number of days spent in stable housing [63]. For 463 
people experiencing homelessness and mental health problems there was some 464 
evidence of positive effects of ICM on housing outcomes, and of CTI on housing 465 
stability [58]. Regarding ACT, de Vet et al. [58] found consistent improvements in 466 
housing stability for people with mental health problems, as well as those with 467 
COSMHAD, to a greater degree than less proactive case management models. 468 
Furthermore, Ponka et al. [63] reported both CTI and ACT to have a promising effect 469 
on housing stability, including more days in community housing, and fewer days 470 
homeless, and, in a US context, families that received CTI transitioned from shelter 471 
to housing more rapidly than the TAU group. 472 
 473 
Emerging evidence suggests that peer support interventions for people who are 474 
homeless and use substances can lead to improved housing outcomes, including 475 
positive effects of IPS on the number of homeless days and return to homelessness 476 




homelessness with problem substance use can lead to positive housing outcomes, 478 
even if unintended, including improved housing in a smoking cessation peer support 479 
programme for people who are homeless with poly-substance use, or being 480 
supported to obtain housing by peers volunteering at safe injection/needle 481 
distribution sites [61].  482 
 483 
Collectively, these reviews all support the HF approach in terms of its effectiveness 484 
in improving housing stability and retention. There is some evidence that supportive 485 
housing can also have a positive effect on housing stability. Peer support 486 
interventions have been found to lead to a decrease in number of days spent 487 
homeless, a reduction in return to homelessness, and other positive housing 488 
outcomes. A range of models of case management can be effective in improving 489 
housing outcomes, particularly for people experiencing homelessness and mental 490 
health problems, for whom ACT and CTI may be effective. 491 
 492 
Treatment outcomes: other 493 
 494 
Sixteen of the included reviews examined outcomes other than housing or substance 495 
use [2,46,63–68,53,55–61], with health and well-being outcomes such as QoL and 496 
frequency of use of health services (including emergency departments, ED), as well 497 
as outcomes relating to crime, incarceration, and participation in community life. 498 
 499 
Permanent supportive housing programmes yielded mixed mental health outcomes 500 
for people experiencing homelessness with mental health problems [56]. Similarly, 501 
the effects of HF on health and well-being outcomes were unclear in the short term, 502 




However, HF clients showed a marked reduction in non-routine use of healthcare 504 
services over TAU which could be an indicator of improvements in health [2]. 505 
Similarly, largely non-significant or mixed results relating to the effects of HF on QoL 506 
were found, as well as for crime, incarceration, participation in community life, and 507 
victimisation [55]. Overall, HF does not seem to result in more positive effects on 508 
mental and physical health, and does not increase social support more than access 509 
to TAU, but there appears to be strong evidence that HF can improve measures of 510 
physical health in the short term for adults who are homeless or at risk of being 511 
homeless [57].  512 
 513 
A range of complex interventions termed “other interventions for people with 514 
mental/physical health problems” [57] illustrate that these interventions provide an 515 
opportunity for recovery, but not everyone benefits. It was noted that some clients do 516 
not benefit or experience harmful effects, including social isolation and loneliness, 517 
when placed in single tenancy accommodation without adequate support [57] 518 
Moreover, interventions for specific groups of housing-vulnerable people presented 519 
largely mixed results regarding reductions in offending [57].   520 
 521 
Reviews of case management interventions showed a positive effect of CTI on 522 
hospitalisation rates for people with problem substance use [58,63], and a similar 523 
effect of ACT on client rehospitalisations [63,67]. However, de Vet et al. [58] found 524 
that, while ACT influenced how people used mental health services, it did not appear 525 
to affect mental health outcomes. Additionally, CTI was found to be better than TAU 526 
in reducing mental health symptoms among those who are homeless with mental 527 




hospital, and other institutional stays, coupled with achieving better long-term results 529 
than TAU, with similar associated costs [58]. Little evidence was found that SCM 530 
could lead to an increased use of services for people experiencing homelessness 531 
and problem substance use, with some evidence that SCM is effective for this group 532 
in removing employment barriers, but limited evidence of this for people who were 533 
homeless with COSMHAD [58]. Furthermore Ponka et al. [63] suggested that SCM 534 
can lead to increases rather than decreases in clients’ hostility and depression. The 535 
evidence base for ICM was limited, with largely non-significant or mixed findings, 536 
potentially partially due to treatment non-adherence [58].  537 
 538 
Concerning programmes for people with COSMHAD, Hwang et al. [59] found that 539 
coordinated programmes for adults who were homeless with mental health problems 540 
or problem substance use generally resulted in better health outcomes than TAU, 541 
including mental health outcomes, and time spent in hospital. This was a finding 542 
similar to that of Minyard et al. [53], who found some evidence for the effectiveness 543 
of an integrated COSMHAD day programme for adults experiencing homelessness 544 
in reducing hospitalisation rates.  545 
 546 
Regarding harm reduction interventions, both Turner et al. [65] and Magwood et al. 547 
[60] found that OST (and OST combined with high NSP coverage) can reduce the 548 
risk of contracting Hepatitis C (HCV), with the combined approach in Turner et al., 549 
[65] reportedly reducing the odds of new HCV infections by nearly 80%, as well as 550 
the risk of HIV infection. Findings on impact of OST on access to care were mixed 551 
[60]. Buprenorphine treatment was found to be associated with better access to 552 




to use opioids more recently were able to access treatment earlier [60]. There was 554 
some evidence that frequent SCF use can be positively associated with experiencing 555 
a non-fatal opioid overdose within the SCF premises, and with a significant decrease 556 
in opioid overdose ED presentations, and with improved access to care for 557 
vulnerable populations [60]. SCF advantages included competent, non-judgemental 558 
staff, education on safer injection, and transfer to other medical (including hospitals) 559 
and social structures [60]. Furthermore, SCFs mediated referrals to services 560 
providing food and shelter and to other broader health support, as well as being 561 
associated with an increase in referrals to a problem substance use treatment centre 562 
and initiation of OST (in this case methadone maintenance therapy most specifically) 563 
[60]. Advice to seek treatment for an ongoing health condition by SCF staff was also 564 
associated with a significantly increased likelihood of receiving treatment [60]. No 565 
systematic reviews reported on the effects of SCFs on mental health outcomes.   566 
 567 
Regarding peer interventions, Barker and Maguire [46] found that all included studies 568 
reported some positive effects of IPS in terms of overall QoL, mental/physical health, 569 
and increased social support. They also suggested that IPS works through 570 
components of shared experience, role modelling, providing social support, and 571 
increasing attendance/interest [46]. Similarly, Miler et al. [61] reported a number of 572 
positive outcomes in their review, such as changes in QoL and use of primary care, 573 
between baseline and six months, in a HF peer support study, and a range of 574 
psycho-socioeconomic benefits, including improvements in physical health, being 575 
able to return to work, and greater community engagement, in a peer support 576 





Immunisation and smoking cessation programmes specifically for people who were 579 
homeless who used drugs resulted in positive health outcomes, including: smoking 580 
abstinence [59]; primary care utilisation in homeless families and children via 581 
outreach services [59]; and reduced subsequent ED visits as a result of 582 
compassionate care being provided from volunteers at ED presentation [59]. 583 
Moreover, sexual health promotion interventions for people who are homeless have 584 
the potential to improve psychosocial functioning [66]; and assertive outreach 585 
programmes for those with mental health problems, as well as informal programmes 586 
to promote sexual health, can lead to lasting physical and/or mental health gains 587 
[68].  588 
 589 
Overall, there is some evidence that permanent supportive housing for people 590 
experiencing homelessness with additional mental health problems can lead to a 591 
reduction in mental health symptoms, and strong evidence that HF can improve 592 
measures of physical health in the short term. There is also evidence that integration 593 
of services and holistic treatment for people with COSMHAD leads to better 594 
psychosocial outcomes. Regarding case management interventions, ACT and CTI 595 
may be most promising for people who are homeless with substance use problems, 596 
given the positive effects on rehospitalisations, as well as reductions in mental health 597 
symptoms among those who are homeless with mental health problems. Moreover, 598 
harm reduction interventions including SCFs can lead to fewer hospitalisations and 599 
ED visits, and peer interventions can lead to changes in QoL and primary care use. 600 
There is also evidence that sexual health promotion interventions for people who are 601 




programmes to promote sexual health and assertive outreach programmes for those 603 
with mental health problems, can lead to lasting physical and/or mental health gains. 604 
 605 
Components of good practice 606 
  607 
Four of the included reviews discussed components of good practice. Carver et al. 608 
[31] explored the views of people who used services and found that both harm 609 
reduction and abstinence-based treatments were considered effective but, in several 610 
studies, harm reduction-oriented services were preferred. However, clients also 611 
reported that abstinence-based treatments should be made available for when 612 
people are ready, highlighting that people who are homeless and experience 613 
problem substance use often desire an integrated approach to treatment. The review 614 
suggested that five components were important for effective treatment: i) the 615 
provision of a facilitative service environment; ii) compassionate and non-616 
judgemental support; iii) adequate time in treatment; iv) choices regarding treatment; 617 
and opportunities to (re)learn how to live; and v) with these being delivered within the 618 
context of good relationships, person-centred care, and an understanding of the 619 
complexity of people’s lives. Longer treatment duration and stability was also valued, 620 
particularly by women [31].  621 
 622 
Sun [71] reported four components of successful strategies for helping people who 623 
are homeless with COSMHAD: i) ensuring an effective transition for individuals with 624 
COSMHAD from an institution (e.g. hospital, foster care, prison, or a residential 625 
programme) into the community; ii) increasing the resources of people who are 626 
homeless with COSMHAD (e.g. helping them apply for government entitlements or 627 




options, and being flexible in meeting housing needs; and iv) engaging individuals in 629 
treatment for COSMHAD. This includes incorporating modified ACT, motivational 630 
interviewing (MI), cognitive behavioural therapy, contingency management, and 631 
COSMHAD-specialised self-help groups. 632 
 633 
Motivation for, and maintenance of, behaviour change was reported as a central 634 
factor for success in community-based services for people experiencing 635 
homelessness and COSMHAD [62]. Called ‘client choice’ in some programmes [62], 636 
this concept facilitated respect for the client’s treatment preference, even if this was 637 
not in line with what was considered the optimum treatment approach. Clients having 638 
input into staffing and programme elements resulted in a programme that was 639 
maximally tailored to their own needs, with data suggesting that both sense of 640 
mastery and perceived level of choice were mediators in the causal pathway 641 
between housing and a person’s psychiatric symptoms.  642 
 643 
Provision of a more supportive, less intensive approach in residential programmes 644 
for people with COSMHAD was found to be a key to success [69]. Programmes 645 
rated by participants as being high in ‘support’, ‘involvement’, and ‘task orientation’, 646 
were associated with better outcomes, although it is not clear how these 647 
characteristics translated into specific programme components. In addition, specific 648 
modifications over the different stages of recovery, with a focus on slower, more 649 
concrete substance use counselling, flexibility in treatment, and greater support and 650 





Collectively, these reviews suggest that flexibility is needed in treatment approaches, 653 
and that support should be tailored to the person. If possible, a combination of 654 
approaches should be used to offer choices to people who may not be ready for/do 655 
not want complete abstinence. Service providers need to be supportive and the 656 
treatment needs to be integrated, comprehensive, holistic, and person-centred, in 657 
order to increase effectiveness. Optimal duration also needs to be considered, with 658 
evidence suggesting that longer treatment leads to better outcomes, as well as being 659 
preferred by clients. 660 
 661 
Treatment entry, engagement, retention and successful 662 
completion  663 
 664 
Twelve of the included reviews mentioned treatment engagement and/or retention 665 
[31,39,70,71,52,54,57–60,67,69] and six mentioned completion rates [46,58,59,68–666 
70], however, only one presented data as completion percentages [70], and one only 667 
provided completion percentages from one of the included studies [58].  668 
 669 
There was some evidence of HF participants having higher rates of retention in a 670 
methadone treatment programme, compared with TF clients, and of increased 671 
engagement with medical treatment and mental health services. However, this was 672 
not the case for all clients, with identified barriers including boredom and isolation 673 
[57]. HF programmes were criticised in another review for a lack of engagement with 674 
services among those with very high levels of problem substance use, suggesting 675 
that TF could achieve better substance use outcomes, since they actively pursue 676 
abstinence from drugs and alcohol [54]. However, TF models have been reported to 677 




participants due to strict regimes, participants becoming ‘stuck’, or participants being 679 
evicted from services due to not meeting the abstention criteria [54]. One TF 680 
approach, called the ‘Birmingham model’, was found to lead to higher than average 681 
completion rates, with reports of 65% of participants completing a programme lasting 682 
24 weeks [70]. 683 
  684 
Regarding case management approaches, de Vet et al. [58] noted participants not 685 
adhering to treatment and a lack of service use between groups in their included ICM 686 
studies. For example, 71% of participants assigned to shelter-based ICM services for 687 
men experiencing both substance use and homelessness did not complete the 688 
programme. On the other hand, Penzenstadler et al. [67] highlighted higher rates of 689 
treatment engagement and retention for ACT, as well as evidence of greater 690 
medication compliance, with significantly higher contact with patients in the ACT and 691 
integrated assertive community treatment (IACT) groups compared with controls. 692 
Overall, the authors concluded that ACT could be a promising approach that may be 693 
useful for promoting treatment engagement for people experiencing problem 694 
substance use.  695 
 696 
Regarding harm reduction, findings on OST retention in treatment were mixed [60]. 697 
There does not appear to be any effect on treatment retention rates whether 698 
buprenorphine was administered under supervised or unsupervised criteria. 699 
However, methadone maintenance therapy was found to be more effective than non-700 
pharmacological approaches in retaining heroin dependent patients in treatment, 701 
with no statistically significant difference in dropout rate between participants in slow 702 




of one pharmacological agent over another on retention outcomes remains unclear. 704 
Naltrexone implants showed significantly better treatment retention than placebo 705 
implants or oral naltrexone, and extended-release naltrexone led to significantly 706 
greater retention in treatment compared to TAU. However, successful completion of 707 
treatment rates did not differ when comparing oral naltrexone versus placebo [60].  708 
 709 
Two studies included in Hwang et al.’s review [59] focusing on the treatment of latent 710 
tuberculosis (TB) for people who are homeless reported that, compared with TAU, a 711 
cash incentive increased attendance at an appointment for initial assessment of a 712 
positive tuberculin skin test. For people experiencing homelessness with latent TB, 713 
receiving directly observed preventive therapy, cash incentives, and non-cash 714 
vouchers at each visit were equally effective in increasing completion rates [59]. In 715 
other studies, there was some evidence that MI and motivational enhancement 716 
therapy (MET) increased treatment engagement in the short term for those 717 
experiencing homelessness and COSMHAD, and some evidence of benefits from 718 
the MI group in terms of increased attendance with aftercare [71]. Regarding 719 
engagement in treatment for people with HIV, Bates et al. [52] reported that 720 
adherence to highly active antiretroviral therapy (HAART) among people who used 721 
drugs was comparable to that among people who did not use drugs. However, 722 
people who used drugs and engaged in OST had increased adherence to HAART 723 
and better treatment outcomes, compared with people who used drugs who engaged 724 
in HAART alone.  725 
 726 
For people with HIV, there was also evidence in support of the use of directly 727 




therapy, to improve treatment and outcomes related to blood-borne virus (BBV) 729 
infections. In terms of people with chronic HCV, there were no significant differences 730 
in BBV treatment dropout between people who inject drugs and those who do not 731 
who received combination treatment for HCV (ribavirin plus recombinant, or 732 
pegylated interferon-α). Lastly, for people experiencing homelessness who also 733 
injected drugs, an accelerated Hepatitis B immunisation schedule (with doses 734 
administered at 0, 7, and 21 days, and a booster at 12 months) resulted in superior 735 
completion rates, compared with traditional schedules with similar seroconversion 736 
rates [68].  737 
 738 
Regarding peer support interventions, Barker and Maguire’s [46] review reported that 739 
their included IPS studies showed baseline data for 1,829 participants and 740 
completed data for 1,341 participants, with a loss to follow-up of 488 or 27% of 741 
participants. The authors [46] reported that one of the included studies suffered such 742 
extreme attrition from its control group that they excluded those data from the 743 
analysis, although the percentage dropout was not reported. This highlights 744 
challenges in retention in research studies for this group. 745 
 746 
Overall, the evidence suggests that engaging and retaining people who are 747 
homeless and have substance use problems in treatment can be difficult, regardless 748 
of intervention type. There is evidence that ACT can lead to increased engagement 749 
rates for people who are homeless and use drugs, and that integrated services for 750 
people with COSMHAD lead to better engagement and retention than segregated 751 
treatments. Results regarding HF suggest that engagement can be difficult and that 752 




the various treatment interventions are rarely reported, but tend to be low for case 754 
management interventions, especially for ICM. 755 
 756 
Discussion  757 
We reviewed evidence from 25 reviews, published between 2004 and 2020, which 758 
explored the effectiveness of treatments and interventions for people experiencing 759 
homelessness and problem drug use. We examined the effects of these approaches 760 
on substance use, housing, and ‘other’ outcomes, as well as treatment entry, 761 
engagement, retention and completion, and components of good practice. A wide 762 
range of interventions were included, with evidence from specialist housing 763 
interventions, residential and community based programmes for people with 764 
COSMHAD, case management, abstinence-based and harm reduction oriented 765 
substance use treatment, healthcare interventions, peer support programmes, ED 766 
interventions, and sexual health promotion. The evidence regarding the 767 
effectiveness of these interventions is mixed. Integrated care for those experiencing 768 
homelessness and problem substance use, or COSMHAD, appeared to be 769 
associated with better outcomes. Harm reduction approaches had positive effects on 770 
drug-related risks, overdose, and other substance use outcomes, as well as on 771 
hospital visits and admissions. Case management, particularly ACT, CTI, and ICM, 772 
had positive effects on problem drug use, housing, and mental health outcomes. 773 
Housing interventions like HF improved housing stability and retention, and were 774 
associated with improvements in physical health, but had little effect on problem drug 775 
use. Relatedly, permanent supportive housing was effective for people experiencing 776 
COSMHAD in reducing poor mental health symptoms. Peer support interventions 777 




positive effects on psychosocial functioning. Moreover, assertive outreach was 779 
associated with positive outcomes for people with COSMHAD in terms of their 780 
physical and mental health. Additionally, treatment approaches require to be flexible, 781 
person-centred, supportive, and integrated. Longer treatment duration, which offers 782 
a range of choices, is optimal. Engagement and retention is challenging, and 783 
assertive outreach and integrated care have the potential to reduce barriers to 784 
treatment.  785 
 786 
It is important to ensure that those experiencing homelessness and problem drug 787 
use are provided with suitable healthcare, housing, and treatment. They are more 788 
likely to experience physical and mental health problems [19], and are at increased 789 
risk of drug related harms and early death than the general population [73,74]. 790 
Access to health and substance use services can be challenging, often due to 791 
negative past experiences, discriminatory services, healthcare costs, and other 792 
administrative barriers [21,22]. It is therefore important to understand the most 793 
effective ways of engaging and retaining people in services to ensure their needs 794 
can be met appropriately. The evidence regarding engagement and retention 795 
highlights the potential of peers and use of incentives with particular groups of 796 
people who are homeless who use drugs.  797 
 798 
Taken together, this review highlights a range of interventions for a heterogeneous 799 
group of people with multiple complex needs: a ‘one size fits all’ approach does not 800 
exist for people experiencing homelessness and problem drug use. A range of 801 
approaches exist and it is likely that the approaches that are most effective are those 802 




addressing health, housing, and drug use in a holistic manner. Given the complexity 804 
of people’s needs and their varied experiences, the included reviews were not 805 
specific to people experiencing homelessness and problem drug use but also 806 
included, amongst others, people who are homeless with COSMHAD. This variability 807 
creates challenges in drawing conclusions on effective interventions for those 808 
experiencing both homelessness and problem drug use. However, our review does 809 
shed light on the types of interventions that are likely to be effective, the needs of 810 
particular sub-populations, and more general components of effective treatment.  811 
 812 
Policy, practice, and research recommendations 813 
Our findings point to the need for a range of harm reduction oriented services to be 814 
available to those experiencing homelessness and problem drug use, including OST, 815 
NSP, SCFs, and peer distribution of THN. ‘Full’ harm reduction should therefore be 816 
made available to ensure people can access support without the expectation of 817 
abstinence. Additional work is also required to support those with BBVs through 818 
increased public health surveillance and research [65]. 819 
 820 
It is clear that the housing situation of individuals has a notable effect on their lives 821 
and should not be dictated by their substance use. Flexible and choice-led 822 
approaches to housing like HF may be beneficial, with more research required to 823 
identify the key components of HF and other approaches [54,70]. Setting clear and 824 
realistic goals, particularly within the context of HF, is important, and services should 825 
recognise that achievable goals will differ between individuals [54]. This review has 826 
highlighted the potential of ACT, SCM, and CTI, and more research is required to 827 




models or specific components are most effective. Current treatment duration is 829 
often relatively short and there is evidence that extended treatment is associated 830 
with improved outcomes and perceived as beneficial [31,75]. Therefore, further 831 
research is also required to identify the optimal length of treatment duration. 832 
Additionally, treatment requires suitable funding to ensure that it can continue for as 833 
long as necessary, so secure funding sources are also recommended. This is 834 
particularly important, but increasingly challenging, in the context of the COVID-19 835 
pandemic, with already vulnerable services closing or restricting access [76,77]. 836 
More research is also required regarding optimal policies on discharge planning for 837 
statutory agencies, which impact on continuity of care [78].  838 
 839 
It is apparent that integrated care and partnership working are important aspects of 840 
providing services to people who are homeless [25]. Integrated mental health and 841 
problem substance use services appear to be particularly important for those 842 
experiencing homelessness and COSMHAD, with secure funding also required for 843 
such services [53]. However, more research is needed regarding such services in 844 
order to establish effective components of integrated programmes of support.  845 
 846 
The way in which services are delivered appears to be vitally important, with 847 
compassionate and non-judgemental staff. It is therefore essential that services 848 
prioritise staff training to support them to gain an understanding of people’s complex 849 
lives, and the need for person-centered approaches, empathy and compassion. The 850 
context in which services are delivered is also crucial. For example, Pleace [39] 851 
noted the need for existing networks and support for joint working, and also to 852 




social care and healthcare systems; general economic conditions; housing and 854 
labour markets; and waiting lists for social rented housing, on the effectiveness of 855 
interventions. Relatedly, involving peers in the delivery of services can be beneficial 856 
and more research is required to fully understand the effect of such individuals at the 857 
intersection of homelessness and problem drug use, as well as the impact of such 858 
services on peer workers themselves.  859 
 860 
More qualitative research is required to understand people’s experiences of the 861 
various approaches, particularly from the viewpoint of sub-groups of people who are 862 
homeless with more complex needs due to their age, gender, ethnicity or sexual 863 
orientation/identity [31]. The heterogeneity of the populations and interventions 864 
included in this review point to the need for more research at the intersection 865 
between homelessness and problem drug use specifically, to ensure that the 866 
interventions for this group of individuals does meet their specific needs. While we 867 
can make suggestions regarding effectiveness, it would be misleading or inaccurate 868 
to base policy and service recommendations on evidence that is not specific to those 869 
experiencing homelessness and problem drug use.   870 
 871 
Strengths and limitations 872 
Steps were taken throughout this review to enhance methodological rigour, including 873 
involvement of at least two people in literature searching, screening, quality 874 
appraisal, data extraction, and analysis. Including quantitative and qualitative 875 
reviews provided a more detailed understanding regarding the effectiveness of 876 




international reviews, including two non-English reviews, to provide a detailed 878 
investigation of the topic.  879 
 880 
Several limitations should be noted. Firstly, some of the included reviews were not 881 
systematic and were limited in their reporting on included studies, thus their findings 882 
should be interpreted with caution. Secondly, some of the reviews are relatively old, 883 
so the included studies are even older. The findings of these studies may be limited 884 
in terms of their relevance today, especially if no newer reviews have been 885 
conducted (e.g. [66]). Thirdly, while most of the reviews were international in focus, 886 
most primary studies were conducted in the USA or Canada, which may limit the 887 
transferability of the findings to countries where there are clear differences in terms 888 




People who experience both homelessness and problem substance use are a 893 
diverse group of people with complex lives and needs. Alongside dealing with the 894 
challenges imposed by homelessness, they are also simultaneously facing issues 895 
relating to their substance use. Many other social and health challenges are also 896 
likely to co-occur, such as mental health problems. There is a large evidence base 897 
regarding interventions for people who are homeless, and for people with problem 898 
substance use, but there is a lack of research focusing on the needs of people who 899 
experience both. Moreover, the evidence suggests that engaging and retaining 900 
people who are homeless and have substance use problems in treatment can be 901 
difficult regardless of intervention type, and completion rates for the various 902 




review highlight the importance of integrating services to ensure a holistic and truly 904 
person-centred approach, as well as underlining the importance of how these 905 
interventions are delivered. We also highlight the need for a long(er)-term focus, 906 
including how individuals are ‘moved on’ into aftercare and what happens after 907 
formal treatment ends. 908 
 909 
Overall, housing interventions, especially HF, have been the focus of much research, 910 
showing consistently positive findings regarding housing outcomes, but mixed results 911 
regarding health and well-being outcomes, with a lack of high-quality evidence on 912 
substance use outcomes. There is some evidence suggesting that harm reduction 913 
approaches can lead to decreases in drug-related risk behaviour, and to decreased 914 
fatal overdoses, as well as to reductions in all-cause mortality, morbidity, and 915 
substance use. There is mixed evidence regarding case management approaches, 916 
however CTI and ICM have been found to be significantly better than TAU in 917 
reducing substance use among people who are homeless, including those with 918 
mental health problems. ACT has also consistently reported positive effects on 919 
housing stability, and been found to be cost-effective, particularly for people with 920 
COSMHAD. Moreover, peer support approaches can lead to positive outcomes in 921 
housing, substance use, and well-being outcomes, as well as having the potential to 922 
have a positive impact on the peers themselves. However, care needs to be taken 923 
when embedding peers in services in order to ensure that they are respected, 924 
valued, and offered meaningful support and training opportunities. 925 
 926 
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